Related Experiment Video

Updated: Dec 28, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.6K

Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression

Anthony Atala

    The Journal of Urology
    |February 20, 2020
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    13.0K
    An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
    08:43

    An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

    Published on: July 28, 2012

    15.1K

    Related Experiment Videos

    Last Updated: Dec 28, 2025

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
    11:02

    Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

    Published on: October 30, 2013

    21.6K
    An Orthotopic Bladder Cancer Model for Gene Delivery Studies
    07:48

    An Orthotopic Bladder Cancer Model for Gene Delivery Studies

    Published on: December 1, 2013

    13.0K
    An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
    08:43

    An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

    Published on: July 28, 2012

    15.1K

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    5.0K
    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.0K

    Articles linked to this work by shared authors, journal, and citation graph.

    A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery.

    Journal of biomedical materials research. Part B, Applied biomaterials·2016

    Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation.

    Stem cell reports·2016

    Common pathway signature in lung and liver fibrosis.

    Cell cycle (Georgetown, Tex.)·2016

    Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink.

    Journal of visualized experiments : JoVE·2016

    Lung-On-A-Chip Technologies for Disease Modeling and Drug Development.

    Biomedical engineering and computational biology·2016

    In Vitro Spermatogenesis: How Far from Clinical Application?

    Current urology reports·2016

    Chemotherapy Versus Surgery for Stage IIA Nonseminomatous Germ Cell Tumor: A Comparative Cost Utility Analysis.

    The Journal of urology·2026

    Bladder Cancer Incidence in Patients with Microhematuria at the Veterans Health Administration.

    The Journal of urology·2026

    Age- and sex-specific prevalence of lower urinary tract symptoms and bowel dysfunction in children: Results from a National Survey.

    The Journal of urology·2026

    ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.

    Molecular cancer research : MCR·2026

    pH-Responsive drug delivery system for tumor therapy.

    Nanoscale·2026

    Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.

    Organic & biomolecular chemistry·2026

    Inducible IL-12 or IL-18 secreting CAR T cells targeting the glyco-antigen CD176 exhibit potent activity against non-small cell lung cancer in preclinical models.

    Cancer immunology research·2026

    Targeting RAS for Pancreatic Cancer Interception.

    Cancer discovery·2026

    Comprehensive Genomic Profiling Beyond Driver Testing in Non-Squamous Non-Small Cell Lung Cancer With Known Drivers.

    Cancer science·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us